Russia Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Russia Blood Glucose Monitoring Market is Segmented by Type (Self-Monitoring Blood Glucose, And Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, And Durables), And Geography. The Report Offers Market Size and Forecasts for all the Above Segments in Value (USD) and Volume (Units).

Russia Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Russia Blood Glucose Monitoring Market Size

View Global Report
Russia Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 575.55 Million
Market Size (2030) USD 881.50 Million
CAGR (2025 - 2030) 8.90 %

Major Players

Russia Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Russia Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Russia Blood Glucose Monitoring Market Analysis

The Russia Blood Glucose Monitoring Market size is estimated at USD 575.55 million in 2025, and is expected to reach USD 881.50 million by 2030, at a CAGR of 8.9% during the forecast period (2025-2030).

Russia is currently facing a significant challenge with the increasing number of diabetes cases, which has major implications for the health of its population. Recent data from the International Diabetes Federation (IDF) reveals that Russia is among the top ten countries worldwide in terms of the number of adults aged 20-79 years living with diabetes. The IDF estimates that approximately 11.4 million adults in Russia have diabetes, affecting around 7.8% of the adult population. This alarming prevalence indicates a growing epidemic that requires immediate attention and collaborative efforts from healthcare authorities and policymakers

There are several factors contributing to the high prevalence of diabetes in Russia. Sedentary lifestyles, poor dietary habits, and a rising rate of obesity are significant drivers of the disease. Moreover, limited access to healthcare services, particularly in remote and rural areas, hinders early diagnosis and proper management of diabetes. Socioeconomic factors, including poverty and disparities in healthcare access, further worsen the situation, disproportionately affecting vulnerable populations.

The implications of the diabetes epidemic in Russia are far-reaching, extending beyond individual health outcomes to socioeconomic burdens on the healthcare system and the overall economy. Complications associated with diabetes, such as cardiovascular disease, kidney failure, and lower limb amputations, place a heavy strain on public health resources and productivity. 

Addressing this crisis necessitates a comprehensive approach that includes preventive measures, early detection, improved healthcare access, and comprehensive management strategies. Collaborative efforts between government agencies, healthcare providers, community organizations, and educational institutions are vital in curbing the prevalence of diabetes and minimizing its impact on the health and well-being of the Russian population.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Russia Blood Glucose Monitoring Industry Overview

The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.

Russia Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Abbott

  3. Dexcom

  4. Medtronics

  5. LifeScan

  6. *Disclaimer: Major Players sorted in no particular order
Russia Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Russia Blood Glucose Monitoring Market News

  • October 2023: Phillips-Medisize, a subsidiary of Molex, specializes in the design, engineering, and manufacturing of pharmaceutical drug delivery, in-vitro diagnostic, and MedTech devices. They have partnered with GlucoModicum, a pioneering medtech company from Finland, to collaborate on the development and eventual launch of a unique non-invasive wearable device. This innovative device aims to overcome obstacles in technology and patient care, specifically in continuous glucose monitoring (CGM).
  • March 2022: DexCom announced the receipt of CE Mark for its G7 CGM system in Europe, intended for people who have diabetes and are two years and older, including pregnant women. With this approval, the highly popular and best-selling real-time CGM in the world is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app.

Russia Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring blood glucose devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous blood glucose monitoring devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Functional Medicine
    • 7.1.12 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Russia Blood Glucose Monitoring Industry Segmentation

A blood glucose monitoring device is a medical tool designed to measure the concentration of glucose in a person's blood. These devices are primarily used by individuals with diabetes to monitor their blood sugar levels, helping them manage their condition effectively. Russia's blood glucose monitoring market is segmented into types. The report offers the value (in USD) and volume (in units) for the above segments.

Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

Russia Blood Glucose Monitoring Market Research FAQs

How big is the Russia Blood Glucose Monitoring Market?

The Russia Blood Glucose Monitoring Market size is expected to reach USD 575.55 million in 2025 and grow at a CAGR of 8.90% to reach USD 881.50 million by 2030.

What is the current Russia Blood Glucose Monitoring Market size?

In 2025, the Russia Blood Glucose Monitoring Market size is expected to reach USD 575.55 million.

Who are the key players in Russia Blood Glucose Monitoring Market?

Roche, Abbott, Dexcom, Medtronics and LifeScan are the major companies operating in the Russia Blood Glucose Monitoring Market.

What years does this Russia Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Russia Blood Glucose Monitoring Market size was estimated at USD 524.33 million. The report covers the Russia Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Russia Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Russia Blood Glucose Monitoring Industry Report

Statistics for the 2025 Russia Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Russia Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.